FDA Inspection 867315 — BioMarin Pharmaceutical Inc.
The FDA completed an inspection of BioMarin Pharmaceutical Inc. on Feb 17, 2014 in San Rafael, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 17, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Rafael, CA (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)